spacer
home > ebr > spring 2019 > trusting in biobanking
PUBLICATIONS
European Biopharmaceutical Review

Trusting in Biobanking

Biobanking is used to create large scale repositories of human biological material, such as blood, urine, tissue, and DNA, to further medical research. Research institutes, hospitals, and biopharmaceutical and biotechnology companies rely on biobanks to advance research of new therapies and for the identification of disease biomarkers from large patient cohorts. Biobanking supports a number of modern research techniques, including genomics and personalised medicine, by allowing researchers to better understand who is most at risk of certain diseases and what treatments they may best respond to. A number of biobanks exist worldwide, each containing hundreds of thousands of samples to contribute to the growing pool of knowledge and safeguarding public health in future generations.

Nuclear Magnetic Resonance and Biobanking

Sample collection, preparation, analysis, storage, transport, and data management must all be highly standardised in biobanking. Samples that are stored over decades can change, and researchers can never guarantee that a sample will remain unchanged over time. The high reproducibility of nuclear magnetic resonance (NMR) spectroscopy makes it an important analytical tool for biobank samples. It can characterise stored samples and determine whether any changes could lead to artefacts.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Matthias Nauck is a Professor at the Institute of Clinical Chemistry at University Medicine Greifswald, Germany. His role is split between a focus on patient care and a range of scientific research projects. Matthias has played an integral role in introducing NMR to the lab at Greifswald for epidemiological research and biobanking studies.
spacer
Matthias Nauck
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Clinical Trial Supply West Coast Conference 2019

Philadelphia, USA – April 24, 2019. This year’s Clinical Trial Supply West Coast Conference will see leading biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) showcasing its specialist clinical trials expertise in relation to scheduled drugs.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement